Literature DB >> 29131550

Innate and acquired immune surveillance in the postdissemination phase of metastasis.

Hugo Gonzalez1, Isabella Robles1, Zena Werb1.   

Abstract

Metastasis is responsible for the majority of death in cancer patients. Of the different steps in the metastasis cascade, the postdissemination phase is perhaps one of the least understood. Many factors, both from the disseminated tumor cells and the microenvironment, impact the success of the metastatic outgrowth. In this article, we discuss the interactions between colonizing cancer cells and immune cells in the period between vascular arrest in a secondary organ and metastatic outgrowth. We address the ambiguity in the findings of current research regarding the role of immune cells in regulating the metastatic microenvironment, and their hand in determining cancer cell fate.
© 2017 Federation of European Biochemical Societies.

Entities:  

Keywords:  disseminated tumor cells; extracellular matrix; immune evasion; metastasis-associated immune cells; metastatic colonization; organ-specific; patient-derived xenograft; tumor dormancy; tumor microenvironment

Mesh:

Year:  2017        PMID: 29131550      PMCID: PMC5826884          DOI: 10.1111/febs.14325

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  82 in total

1.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.

Authors:  Asaf Spiegel; Mary W Brooks; Samin Houshyar; Ferenc Reinhardt; Michele Ardolino; Evelyn Fessler; Michelle B Chen; Jordan A Krall; Jasmine DeCock; Ioannis K Zervantonakis; Alexandre Iannello; Yoshiko Iwamoto; Virna Cortez-Retamozo; Roger D Kamm; Mikael J Pittet; David H Raulet; Robert A Weinberg
Journal:  Cancer Discov       Date:  2016-04-12       Impact factor: 39.397

2.  Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival.

Authors:  Matteo Donadon; Kelly Hudspeth; Matteo Cimino; Luca Di Tommaso; Max Preti; Paolo Tentorio; Massimo Roncalli; Domenico Mavilio; Guido Torzilli
Journal:  J Gastrointest Surg       Date:  2017-05-23       Impact factor: 3.452

Review 3.  Prospects for combining targeted and conventional cancer therapy with immunotherapy.

Authors:  Philip Gotwals; Scott Cameron; Daniela Cipolletta; Viviana Cremasco; Adam Crystal; Becker Hewes; Britta Mueller; Sonia Quaratino; Catherine Sabatos-Peyton; Lilli Petruzzelli; Jeffrey A Engelman; Glenn Dranoff
Journal:  Nat Rev Cancer       Date:  2017-03-24       Impact factor: 60.716

4.  Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

Authors:  S E Street; E Cretney; M J Smyth
Journal:  Blood       Date:  2001-01-01       Impact factor: 22.113

5.  Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells.

Authors:  Quanrongzi Wang; Min Feng; Tongfu Yu; Xisheng Liu; Peijian Zhang
Journal:  Cell Immunol       Date:  2014-01-10       Impact factor: 4.868

6.  Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells.

Authors:  Jonathan D Spicer; Braedon McDonald; Jonathan J Cools-Lartigue; Simon C Chow; Betty Giannias; Paul Kubes; Lorenzo E Ferri
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

Review 7.  Granzymes in cancer and immunity.

Authors:  S P Cullen; M Brunet; S J Martin
Journal:  Cell Death Differ       Date:  2010-01-15       Impact factor: 15.828

8.  Genome-wide in vivo screen identifies novel host regulators of metastatic colonization.

Authors:  Louise van der Weyden; Mark J Arends; Andrew D Campbell; Tobias Bald; Hannah Wardle-Jones; Nicola Griggs; Martin Del Castillo Velasco-Herrera; Thomas Tüting; Owen J Sansom; Natasha A Karp; Simon Clare; Diane Gleeson; Edward Ryder; Antonella Galli; Elizabeth Tuck; Emma L Cambridge; Thierry Voet; Iain C Macaulay; Kim Wong; Sarah Spiegel; Anneliese O Speak; David J Adams
Journal:  Nature       Date:  2017-01-04       Impact factor: 49.962

9.  Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

Authors:  Qiong-wen Zhang; Lei Liu; Chang-yang Gong; Hua-shan Shi; Yun-hui Zeng; Xiao-ze Wang; Yu-wei Zhao; Yu-quan Wei
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.

Authors:  Lee Pai-Scherf; Gideon M Blumenthal; Hongshan Li; Sriram Subramaniam; Pallavi S Mishra-Kalyani; Kun He; Hong Zhao; Jingyu Yu; Mark Paciga; Kirsten B Goldberg; Amy E McKee; Patricia Keegan; Richard Pazdur
Journal:  Oncologist       Date:  2017-08-23
View more
  19 in total

Review 1.  Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.

Authors:  Frank C Cackowski; Russell S Taichman
Journal:  Bone       Date:  2018-02-26       Impact factor: 4.398

Review 2.  Neurodevelopmental disorders, immunity, and cancer are connected.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  iScience       Date:  2022-05-30

3.  Cellular architecture of human brain metastases.

Authors:  Hugo Gonzalez; Wenbin Mei; Isabella Robles; Catharina Hagerling; Breanna M Allen; Trine Line Hauge Okholm; Ankitha Nanjaraj; Tamara Verbeek; Sandhya Kalavacherla; Merel van Gogh; Stephen Georgiou; Mariza Daras; Joanna J Phillips; Matthew H Spitzer; Jeroen P Roose; Zena Werb
Journal:  Cell       Date:  2022-01-20       Impact factor: 41.582

Review 4.  Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.

Authors:  Jörg Wischhusen; Ignacio Melero; Wolf Herman Fridman
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

5.  The inflammation - cancer connection.

Authors:  Alberto Mantovani
Journal:  FEBS J       Date:  2018-02       Impact factor: 5.542

6.  A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.

Authors:  Chunlai Yu; Mingliang You; Peizhen Zhang; Sheng Zhang; Yuzhu Yin; Xiao Zhang
Journal:  Cancer Med       Date:  2021-06-14       Impact factor: 4.452

Review 7.  Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix.

Authors:  Mark Owyong; Gizem Efe; Michael Owyong; Aamna J Abbasi; Vaishnavi Sitarama; Vicki Plaks
Journal:  Front Cell Dev Biol       Date:  2018-03-01

Review 8.  Roles of the immune system in cancer: from tumor initiation to metastatic progression.

Authors:  Hugo Gonzalez; Catharina Hagerling; Zena Werb
Journal:  Genes Dev       Date:  2018-10-01       Impact factor: 11.361

9.  Enrichment and detection of bone disseminated tumor cells in models of low tumor burden.

Authors:  Miranda E Sowder; Rachelle W Johnson
Journal:  Sci Rep       Date:  2018-09-24       Impact factor: 4.379

10.  CALCB rs3829222 T/T Genotype and Low Expression of CALCB Are High-Risk Factors for Adenoid Cystic Carcinoma of Salivary Gland.

Authors:  Chaobin Dai; Bin Zhang; Yunyang Liao; Qicai Liu; Feiguang Wu; Xiaoting Lv; Kai Zeng; Xiaofeng Zhu
Journal:  Dis Markers       Date:  2021-06-12       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.